Amgen (AMGN), Allergan (AGN) Announce Results from ABP 980 Phase 3 in HER2+ Breast Cancer; Superiority Not Ruled Out
Tweet Send to a Friend
Amgen (Nasdaq: AMGN) and Allergan plc (NYSE: AGN) announced results from a Phase 3 study evaluating efficacy and safety of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
